Cargando…

Adding metoclopramide to paroxetine induced extrapyramidal symptoms and hyperprolactinemia in a depressed woman: a case report

A 54-year-old Japanese woman was diagnosed with major depressive disorder and prescribed paroxetine 20 mg/day. In around May 2013, the patient experienced gastric discomfort, so metoclopramide was prescribed. Beginning on June 4, 2013, the patient was given metoclopramide, 10 mg intravenously, twice...

Descripción completa

Detalles Bibliográficos
Autores principales:	Igata, Ryohei, Hori, Hikaru, Atake, Kiyokazu, Katsuki, Asuka, Nakamura, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012626/ https://www.ncbi.nlm.nih.gov/pubmed/27621638 http://dx.doi.org/10.2147/NDT.S116686

Ejemplares similares

Influence of fluvoxamine on plasma interleukin-6 or clinical improvement in patients with major depressive disorder
por: Yoshimura, Reiji, et al.
Publicado: (2017)

Blood Biomarkers Predict the Cognitive Effects of Aripiprazole in Patients with Acute Schizophrenia
por: Hori, Hikaru, et al.
Publicado: (2017)

Relationships between brain-derived neurotrophic factor, clinical symptoms, and decision-making in chronic schizophrenia: data from the Iowa Gambling Task
por: Hori, Hikaru, et al.
Publicado: (2014)

Catechol-O-methyltransferase Val158Met genotype and the clinical responses to duloxetine treatment or plasma levels of 3-methoxy-4-hydroxyphenylglycol and homovanillic acid in Japanese patients with major depressive disorder
por: Atake, Kiyokazu, et al.
Publicado: (2015)

The Impact of Aging, Psychotic Symptoms, Medication, and Brain-Derived Neurotrophic Factor on Cognitive Impairment in Japanese Chronic Schizophrenia Patients
por: Atake, Kiyokazu, et al.
Publicado: (2018)

Risk factors for further sick leave among Japanese workers returning to work after an episode of major depressive disorder: a prospective follow-up study over 1 year
por: Hori, Hikaru, et al.
Publicado: (2019)

Serum levels of brain-derived neurotrophic factor (BDNF), proBDNF and plasma 3-methoxy-4-hydroxyphenylglycol levels in chronic schizophrenia
por: Yoshimura, Reiji, et al.
Publicado: (2016)

Effects of Continuing Oral Risperidone vs. Switching from Risperidone to Risperidone Long-Acting Injection on Cognitive Function in Stable Schizophrenia Patients: A Pilot Study
por: Hori, Hikaru, et al.
Publicado: (2018)

Effect of single caffeine intake on neuropsychological functions in healthy volunteers: A double-blind placebo-controlled study
por: Konishi, Yuki, et al.
Publicado: (2018)

Duloxetine, a Selective Noradrenaline Reuptake Inhibitor, Increased Plasma Levels of 3-Methoxy-4-hydroxyphenylglycol but Not Homovanillic Acid in Patients with Major Depressive Disorder
por: Atake, Kiyokazu, et al.
Publicado: (2014)

Serum proBDNF/BDNF and response to fluvoxamine in drug-naïve first-episode major depressive disorder patients
por: Yoshimura, Reiji, et al.
Publicado: (2014)

Isolated Lingual Dystonia as the Manifestation of Acute Extrapyramidal Syndrome Induced by Metoclopramide
por: Verma, Rajesh, et al.
Publicado: (2019)

Follow-up Study on Electroconvulsive Therapy in Treatment-resistant Depressed Patients after Remission: A Chart Review
por: Tokutsu, Yuki, et al.
Publicado: (2013)

Baricitinib/ceftriaxone/metoclopramide: Extrapyramidal syndrome and off label use: case report
Publicado: (2021)

Serum Brain-Derived Neurotrophic Factor, and Plasma Catecholamine Metabolites in People with Major Depression: Preliminary Cross-Sectional Study
por: Yoshimura, Reiji, et al.
Publicado: (2018)

Serum Levels of Brain-Derived Neurotrophic Factor at 4 Weeks and Response to Treatment with SSRIs
por: Yoshimura, Reiji, et al.
Publicado: (2014)

Prolonged extrapyramidal symptoms induced by long‐term, intermittent administration of low‐dose olanzapine along with metoclopramide for emesis: A case report
por: Sakamoto, Shoko, et al.
Publicado: (2022)

PCLO rs2522833-mediated gray matter volume reduction in patients with drug-naive, first-episode major depressive disorder
por: Igata, R, et al.
Publicado: (2017)

Extrapyramidal side effects after metoclopramide administration in a post-anesthesia care unit -A case report-
por: Jo, Youn Yi, et al.
Publicado: (2012)

Escitalopram-induced extrapyramidal symptoms
por: Kumar, Pattath Narayanan Suresh, et al.
Publicado: (2019)

Cerebrospinal fluid α synuclein concentrations in patients with positive AD biomarkers and extrapyramidal symptoms
por: Winkel, Izabela, et al.
Publicado: (2021)

Depression, extrapyramidal symptoms, dementia and an unexpected outcome: a case report
por: Tsolaki, Magda, et al.
Publicado: (2010)

Relationship between interleukin (IL)-6 and brain morphology in drug-naïve, first-episode major depressive disorder using surface-based morphometry
por: Kakeda, Shingo, et al.
Publicado: (2018)

Long-lasting extrapyramidal symptoms after multiple injections of paliperidone palmitate to treat schizophrenia
por: Takada, Ryohei, et al.
Publicado: (2018)

Relationship between white matter integrity and serum inflammatory cytokine levels in drug-naive patients with major depressive disorder: diffusion tensor imaging study using tract-based spatial statistics
por: Sugimoto, Koichiro, et al.
Publicado: (2018)

Specific Pharmacological Effects of Paroxetine Comprise Psychological but Not Somatic Symptoms of Depression
por: Schalet, Benjamin D., et al.
Publicado: (2016)

Adding metoclopramide to lidocaine for intravenous regional anesthesia in trauma patients
por: Safavi, Mohammadreza, et al.
Publicado: (2014)

FLUOXETINE INDUCED EXTRAPYRAMIDAL SYMPTOMS : CASE REPORTS
por: Nizamie, S. Haque, et al.
Publicado: (1998)

Chronic subdural haematoma mimicking extrapyramidal symptoms
por: Cheng, Po Wen, et al.
Publicado: (2023)

Effectiveness of paroxetine in the treatment of poststroke depression
por: Ma, Chen, et al.
Publicado: (2018)

Hyperprolactinemia
por: Majumdar, Abha, et al.
Publicado: (2013)

Structural Changes in Hippocampal Subfields in Patients with Continuous Remission of Drug-Naive Major Depressive Disorder
por: Katsuki, Asuka, et al.
Publicado: (2020)

A Rare Case of Idiopathic Granulomatous Mastitis in a Nulliparous Woman with Hyperprolactinemia
por: Agrawal, Ankit, et al.
Publicado: (2019)

Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychotics
por: Boloc, Daniel, et al.
Publicado: (2018)

Brainstem atrophy is linked to extrapyramidal symptoms in frontotemporal dementia
por: Heikkinen, Sami, et al.
Publicado: (2022)

Abnormal White Matter Integrity in the Corpus Callosum among Smokers: Tract-Based Spatial Statistics
por: Umene-Nakano, Wakako, et al.
Publicado: (2014)

Extrapyramidal syndrome in psychotic depression: a case report.
por: Álvarez, C., et al.
Publicado: (2023)

Critical appraisal of paroxetine for the treatment of vasomotor symptoms
por: Carroll, Dana G, et al.
Publicado: (2015)

Paroxetine in the treatment of recurrent brief depressive disorder
por: Prakash, Sathya, et al.
Publicado: (2013)

Agomelatine versus paroxetine in treating depressive and anxiety symptoms in patients with chronic kidney disease
por: Chen, Jian-wei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qkcmd9ko620rrmjvs055j2998d